Clin2
NCT07036601Likely a fitRecruiting

Study of THDBH120 for weight loss in overweight or obese adults

Overweight or Obese

Part of Hormones & metabolism clinical trials.

This trial tests an injection called THDBH120 to help people who are overweight or obese lose weight. You may qualify if you have a BMI of 28 or higher, or a BMI of 24 to 28 with a weight-related health issue like prediabetes or high blood pressure, and you have been exercising and eating healthy for the past 3 months.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
276 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have a BMI of 28 or more, or a BMI between 24 and 28 with at least one weight-related health problem (like prediabetes, high blood pressure, fatty liver, or joint pain).
  • You have been trying to lose weight with diet and exercise for at least 3 months and your weight has stayed mostly the same (changed less than 5%).
  • You do not have diabetes.
  • Your high blood pressure is well-controlled (systolic under 160 and diastolic under 100).
  • Your heart rhythm is normal on an ECG (no slow or fast resting heart rate, no long QT or heart block).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06886126Recruiting· Phase 2
Testing HDM1005 injection for weight loss in adults with obesity

This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.

Nanjing
NCT07224399Recruiting· Phase 1
Testing a new injection for weight loss in obesity

This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.

Baltimore, Maryland
NCT07192263Not yet recruiting· Phase 3
Weight loss injection study for adults with obesity

This study tests an investigational weight-loss injection, IN-B00009, for adults with obesity or overweight who don't have diabetes. It aims to see if the drug is safe and effective for helping you lose weight, along with diet and exercise.

NCT07184502Recruiting· Phase 1
Testing a new injection for weight loss in healthy and overweight adults

This trial tests an investigational injection called ZT003 to see if it is safe and how the body processes it. It is for healthy volunteers or those who are overweight or obese, to help understand how this treatment might work.

Brisbane, Queensland
NCT07294235Recruiting· Phase 1
Study of BGM1812 injection for healthy and overweight or obese participants

This trial tests an investigational drug called BGM1812 given as an injection. It is for healthy Chinese adults who are either at a normal weight or are overweight/obese but not diabetic. The study will see how the drug works in the body and check for side effects.

Kunming, Yunnan
NCT07279194Recruiting· Phase 3
Study of HDM1005 for weight loss in Chinese adults without diabetes

This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.

Shanghai

Hear when a new Overweight or Obese trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.